14 Nov 2018 | 5:49 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
655.00
-20.90
(-3.09 %)
14 Nov 2018 | 04:01 PM
Change company
  • Open (Rs)
    688.00
  • Prev. close (Rs.)
    675.90
  • High (Rs.)
    688.00
  • Low (Rs.)
    643.96
  • 52W H (Rs.)
    704.65
  • 52W L (Rs.)
    483.60
  • Volume
    159918
  • MCap (Rs in Cr.)
    18,482.01
656.1
-23.00
(-3.39 %)
  • Open (Rs)
    685.05
  • High (Rs)
    686.75
  • Low (Rs)
    643.75
  • Prev. close(Rs)
    679.10
  • Contracts Tra.
    50,54,000
  • Turnover (Cr.)
    334
  • Open Interest
    39,12,000
  • Open Int. chg
    47,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
28.49
Operating Margin (%)
17.80
Gross Profit Margin (%)
14.47
Net Profit Margin (%)
8.85
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
8.44
Earning Retention Ratio
91.56

News

09 Nov 2018 - 07:50:00-Glenmark Pharmaceuticals Thursday said it will launch phase 1 trial in solid tumors for its bispecif...
01 Nov 2018 - 12:14:00-Glenmark Pharmaceuticals Thursday announced the launch of Nourkrin used to treat hair loss in the Ru...
30 Oct 2018 - 11:24:00-Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator fo...
26 Oct 2018 - 14:23:00-Glenmark Pharmaceuticals Friday said its US arm has received final nod from the US health regulator ...

Announcements

13-Nov-2018
Glenmark Pharma - Outcome Of The Board Meeting - November 13 2018
13-Nov-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
08-Nov-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
08-Nov-2018
Glenmark Pharma - Press Release
05-Nov-2018
Glenmark Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

Religare Research

13 Nov 2018 | 02:51 PM
Godrej Consumer Products Ltd’s (GCPL) Q2FY19 numbers were muted, especially on the profit front. Net...
13 Nov 2018 | 02:49 PM
Capacit’e Infraprojects (Capacit’e) reported strong set of numbers led by robust execution. Its net ...
13 Nov 2018 | 01:30 PM
Godrej Agrovet Ltd (GAVL)’s Q2FY19 revenue was in-line with estimates, while higher expenses impacte...
13 Nov 2018 | 12:45 PM
Minda Corp reported decent set of numbers, which were only marginally lower than our estimates. Its ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 71.40 0.49
10,00,000 115.06 59.16 0.49
10,00,000 115.06 199.46 0.49
10,00,000 115.06 209.37 0.50
10,00,000 115.06 75.72 0.50

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI4.28%
FI/Banks3.01%
Insurance3.01%
FII30.90%
Government0.00%
Others5.46%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,605.00(1.25)
3280
 Sanofi India Ltd.
6,100.00(0.23)
3325
 Pfizer Ltd.
2,799.75(-2.16)
3370
 Dr. Reddy`s Laboratories Ltd.
2,448.00(0.52)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.39.0069.55151.55
NIFTY(S&P CNX)63.80-779.45-230.30
BSE SENSEX276.89-2,502.91-414.72
BSE 500165.10-1,179.49-738.73

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda